Japan’s 2024 Pharmaceutical Market Overview — Record High for the Second Consecutive Year

Introduction to the 2024 Pharmaceutical Market According to the article (24年度国内医療用薬市場　２年連続で11兆円台、会計年度でも最高額更新　キイトルーダ1900億円超え | ニュース | ミクスOnline) published by MixOnline, Japan’s pharmaceutical market for FY2024 (April 2024 – March 2025) reached 11.4874 trillion yen (based on NHI price), representing a 1.0% increase from the previous year. This marks the second consecutive year the market has remained above 11 […]

2024 Top-Selling Pharmaceuticals in Japan

Overview of Japan’s Pharmaceutical Market in 2024  According to the news (【2024年国内医薬品売上高トップ10】キイトルーダ、1851億円で首位…2位にリクシアナ、「共連れ」のオプジーボは3位 | AnswersNews) released by AnswersNews on 01/27/2025, In 2024, MSD’s immune checkpoint inhibitor, Keytruda, led Japan’s pharmaceutical market with sales reaching ¥185.1 billion. Following closely, Daiichi Sankyo’s anticoagulant, Lixiana, secured the second position with ¥147.7 billion in sales, slightly surpassing Ono Pharmaceutical’s Opdivo, […]